Bote G. Bruinsma, MD PhD
Harvard University
H-index: 20
North America-United States
Top articles of Bote G. Bruinsma, MD PhD
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Devices and methods to improve and assess viability of human livers | 2024/3/5 | ||
836-P: glucose-dependent insulin production and insulin-independence in type 1 diabetes from stem cell–derived, fully differentiated islet cells—Updated data from the Vx-880 … | Diabetes | TREVOR W Reichman CAMILLO Ricordi ALI Naji JAMES F Markmann BRUCE A Perkins | 2023/6/20 |
Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor | Journal of Cystic Fibrosis | Isabelle Fajac Cori Daines Isabelle Durieu Jennifer L Goralski Harry Heijerman | 2023/1/1 |
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function … | American journal of respiratory and critical care medicine | Marcus A Mall Rossa Brugha Silvia Gartner Julian Legg Alexander Moeller | 2022/12/1 |
Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week … | The Lancet Respiratory Medicine | Sivagurunathan Sutharsan Edward F McKone Damian G Downey Jamie Duckers Gordon MacGregor | 2022/3/1 |
Tezacaftor/ivacaftor in people with cystic fibrosis who stopped lumacaftor/ivacaftor due to respiratory adverse events | Journal of Cystic Fibrosis | Carsten Schwarz Sivagurunathan Sutharsan Ralph Epaud Ross C Klingsberg Rainald Fischer | 2021/3/1 |
Real-world clinical effectiveness of elexacaftor/tezacaftor/ivacaftor and ivacaftor in people with CF: Interim results from the HELIO study | Journal of Cystic Fibrosis | V Ganapathy E Bailey K Mortimer Y Lou J Yuan | 2021/11/1 |
Co-Authors
